Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
OBJECTIVE: To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). METHOD: We used 4-month open label follow-up data from routine memory clinic patients. There were 852 patients with AD and 112...
Main Authors: | Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2009
|
Registos relacionados
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Por: Rolinski, M, et al.
Publicado em: (2012) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
Por: Ballard, C, et al.
Publicado em: (2007) -
Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
Por: Chalmers, K, et al.
Publicado em: (2008) -
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
Por: McShane, R, et al.
Publicado em: (2001) -
Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
Por: Shifu Xiao, et al.
Publicado em: (2019-02-01)